Report cover image

Global Beta Inosine Market - 2024-2031

Publisher DataM Intelligence 4Market Research LLP
Published Aug 07, 2024
Length 186 Pages
SKU # DTAM19056074

Description

Global Beta Inosine Market - 2024-2031


Global Beta Inosine Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031

Inosine, a nucleoside formed when hypoxanthine is attached to a ribose ring, is crucial for gene translation in wobble base pairs. It is found in tRNAs and has led to advancements in immunotherapy.

Inosine monophosphate is oxidized by the enzyme inosine monophosphate dehydrogenase, producing xanthosine monophosphate, a precursor in purine metabolism. Mycophenolate mofetil, an anti-metabolite drug, inhibits inosine monophosphate dehydrogenase and is used in treating autoimmune diseases like granulomatosis with polyangiitis this is because B cells' purine uptake can exceed 8 times that of normal body cells, targeting white cells that cannot operate purine salvage pathways.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of parkinson’s disease

The increasing prevalence of Parkinson's disease is driving the market for inosine, a compound with potential neuroprotective effects. Inosine, metabolized to urate, has been linked to reduced risk of Parkinson's disease and slower progression. The pharmaceutical industry is investing in clinical trials and drug development programs to explore inosine's efficacy and safety for Parkinson's disease patients.

For instance, according to the Parkinson’s Foundation, around one million people in the U.S. suffer from Parkinson's disease, the second-most common neurodegenerative disease after Alzheimer's. The disease affects around 90,000 people in the U.S. annually and over 10 million worldwide. The incidence increases with age, with 4% diagnosed before age 50. Men are 1.5 times more likely to develop Parkinson's disease than women.

Side effects associated with the inosine

There are ongoing concerns regarding the safety and long-term effects of inosine supplementation, particularly at higher doses. Potential side effects and adverse reactions could lead to stricter regulations and cautious adoption . The common side effects that a individual who are on the treatment with inosine pranobex are nausea, stomach discomfort, increased liver enzymes and blood urea nitrogen, itching, skin rashes, headaches, vertigo, fatigue or malaise (feeling unwell), joint pain.

Segment Analysis

The global beta inosine market is segmented based on product type, form, application, end-user and region.

The pharmaceutical grade from the product type segment accounted for approximately 47.3%. of the beta inosine market share

The pharmaceutical grade from the product type segment accounted for approximately 47.3%. Pharmaceutical grade Beta Inosine is a versatile compound with several capacity therapeutic programs, specifically in areas requiring stronger energy metabolism, neuroprotection, and immune support. Its excessive purity and fineness make it suitable for use in numerous pharmaceutical formulations aimed at treating and dealing with an extensive range of health situations.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like the novel product launches, FDA approvals, advanced healthcare infrastructure in the region, collaborations and partnerships and others help the region to grow during the forecast period.

For instance, in October 2023, ZS, a global management consulting and technology firm, announced the launch of the AI-powered ZAIDYN Beta Inosine solution, part of the ZAIDYN by ZS platform. ZAIDYN Beta Inosine helps pharmaceutical companies, healthcare providers and payers innovate so they can understand unmet needs, better engage with patients and improve health outcomes. In an evolving healthcare ecosystem, it’s vital for these entities to have intelligence they can trust.

Market Segmentation

By Product Type
• Pharmaceutical Grade
• Food Grade
• Industrial Grade

By Form
• Powder
• Capsules/Tablets
• Liquids

By Application
• Multiple Sclerosis (MS)
• Parkinson's Disease
• Others

By End User
• Healthcare and Pharmaceuticals
• Food and Beverage
• Biotechnology
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Merck KGaA, LGC Limited, Combi-Blocks Inc, Tokyo chemical industry, Thermo Fisher Scientific, Parchem fine & specialty chemicals, Aronis compounds, ChemTik, AK Scientific Inc among others.

Why Purchase the Report?
• To visualize the global beta inosine market segmentation based on product type, form, application, end user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the beta inosine market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global beta inosine market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

186 Pages
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the prevalence of Parkinson’s diseases
4.1.1.2. Rise in the development of novel drug delivery
4.1.2. Restraints
4.1.2.1. Side effects associated with the inosine
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Pharmaceutical Grade *
6.2.1. Introduction
6.3. Food Grade
6.4. Industrial Grade
7. By Form
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
7.1.2. Market Attractiveness Index, By Form
7.2. Powder*
7.2.1. Introduction
7.3. Capsules/Tablets
7.4. Liquids
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2. Market Attractiveness Index, By Application
8.3. Multiple Sclerosis (MS)*
8.3.1. Introduction
8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.4. Parkinson's Disease
8.5. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Healthcare and Pharmaceuticals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Food and Beverage
9.4. Biotechnology
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Merck KGaA*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. LGC Limited
12.3. Combi-Blocks Inc
12.4. TOKYO CHEMICAL INDUSTRY
12.5. Thermo Fisher Scientific
12.6. Parchem fine & specialty chemicals
12.7. Aronis compounds
12.8. ChemTik
12.9. AK Scientific Inc
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us